Scailyte Quarterly Update, January 2021

Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV2 infection

Read more

Scailyte Quarterly Update, April 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

VACANCY: Director of Biomarker Discovery

Read more

Scailyte and Geninus announce a strategic partnership to develop a predictive assay for immune-checkpoint inhibitors in Non-Small Cell Lung Cancer patients

Artificial Intelligence (AI)-driven biomarker discovery innovator Scailyte and the global single-cel

Read more

Scailyte and Volv Global announce strategic partnership to accelerate rare disease patient diagnosis

Two Artificial Intelligence (AI)-driven biomarker discovery companies Scailyte and Volv Global today

Read more

Scailyte Quarterly Update, January 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

ScaiVision® performs best-in-class at sample class prediction!

ScaiVision® v1.0.0 was released internally and benchmarked in a massive experiment, outperforming a

Read more

Scailyte participates @ swissnex san francisco DEMO DAY!

Striving to internationalize and network, Scailyte participates and pitches at the swissnex Demo Day

Read more